Israel - englanti - Ministry of Health

neopharm ltd - azacitidine 100 mg - lyophilized powder for suspension for injection - azacitidine - for the treatment of patients with the following myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.

Euroopan unioni - englanti - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidine - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastic agents - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification.vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.

Kanada - englanti - Health Canada

bristol-myers squibb canada - azacitidine - powder for suspension - 100mg - azacitidine 100mg - antineoplastic agents

Kanada - englanti - Health Canada

dr reddy's laboratories ltd - azacitidine - powder for suspension - 100mg - azacitidine 100mg - antineoplastic agents

Kanada - englanti - Health Canada

dr reddy's laboratories ltd - azacitidine - powder for suspension - 100mg - azacitidine 100mg - antineoplastic agents

Kanada - englanti - Health Canada

natco pharma (canada) inc - azacitidine - powder for suspension - 100mg - azacitidine 100mg - antineoplastic agents

Israel - englanti - Ministry of Health

abic marketing ltd, israel - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azacitidine teva is indicated for treatment of patients with the following french-american- british (fab) myelodysplastic syndrome subtypes: refractory anemia (ra) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (raeb), refractory anemia with excess blasts in transformation (raeb-t), and chronic myelomonocytic leukemia (cmmol).

Israel - englanti - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azadine is indicated for treatment of patients with the following french-american- british (fab) myelodysplastic syndrome subtypes: refractory anemia (ra) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (raeb), refractory anemia with excess blasts in transformation (raeb-t), and chronic myelomonocytic leukemia (cmmol).

Saudi-Arabia - englanti - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

celgene europe ltd, netherlands - azacitidine - powder for suspension for injection - 100 mg

Saudi-Arabia - englanti - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sudair pharma company, saudi arabia - azacitidine - powder for suspension for injection - 100 mg,